Papers

6

Total Citations

54

H-Index

5

About

Takatsugu Fujii is a pioneering surgical researcher specializing in minimally invasive and robot-assisted colorectal cancer surgery, with a particular focus on the Senhance Digital Laparoscopy System. As an early adopter and champion of this innovative robotic platform — the first institution in Japan to introduce it — Fujii and his team have generated a significant body of evidence evaluating its clinical utility, safety, and patient outcomes. His most-cited work, a 2022 study reporting short-term results in 55 colorectal cancer patients (28 citations), laid critical groundwork for understanding the system's real-world performance. Fujii has systematically expanded this research through comparative studies, propensity score matching analyses, and case reports documenting surgical firsts, including the inaugural single-incision plus one-port transverse colectomy using the Senhance system. His 2024 comparative outcomes study and 2025 investigations into postoperative inflammation and pain further demonstrate his commitment to rigorous, patient-centered evaluation of emerging technologies. Collectively, his work has helped establish a clinical evidence base that bridges laparoscopic and robotic surgery, informing adoption decisions for surgical teams worldwide and advancing the standard of care in colorectal oncology.

Research Focus

Key Achievements

5
H-Index
6
Papers
54
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Short‐term results of robot‐assisted colorectal cancer surgery using Senhance Digital Laparoscopy System
28 citations · 2022
📈 Most Prolific Year: 2025 (2 Papers)
🤝 Key Collaborators: 31
🏛 Institutions: Saitama Medical University, Saitama International Medical Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago